Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Dis Child Fetal Neonatal Ed ; 87(1): F34-6, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12091288

ABSTRACT

BACKGROUND: The pathogenesis of posthaemorrhagic hydrocephalus (PHHC) following intraventricular haemorrhage (IVH) in premature infants includes a fibroproliferative reaction leading to arachnoidal fibrosis, ultimately causing malresorption of cerebrospinal fluid (CSF) at the arachnoid villi. AIMS: To determine whether an increased concentration of the carboxyterminal propeptide of type I procollagen (PICP) in the CSF of neonates after IVH reflects the activation of collagen synthesis preceding the manifestation of PHHC. METHODS: From 20 neonates with PHHC (median birth weight 740 g, median gestational age 25+1 weeks), 52 CSF samples were collected. CSF samples of four neonates (median birth weight 2170 g, median gestational age 32+4 weeks) with congenital non-haemorrhagic hydrocephalus served as controls. PICP was measured by radioimmunoassay. RESULTS: PICP in CSF taken at the start of external CSF drainage (median day 21, range 17-25 days postnatal age) was significantly increased (median 851.5, range 153.5-1944 microg/l) compared with controls (median 136.1, range 33.8-169.5 microg/l). CSF concentrations of PICP declined until permanent shunt placement (median day 70, range days 41-113). CONCLUSION: In neonates who develop PHHC, significant elevation of PICP concentration in the CSF is present 3-4 weeks after IVH. It reflects the increase of local type I collagen turnover, thereby correlating with manifestation of PHHC.


Subject(s)
Cerebral Hemorrhage/cerebrospinal fluid , Hydrocephalus/cerebrospinal fluid , Infant, Premature, Diseases/cerebrospinal fluid , Peptide Fragments/cerebrospinal fluid , Procollagen/cerebrospinal fluid , Birth Weight , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/congenital , Female , Humans , Hydrocephalus/etiology , Infant, Newborn , Infant, Premature , Male , Prospective Studies , Radioimmunoassay/methods
2.
Pediatr Pulmonol ; 31(5): 331-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11340678

ABSTRACT

Chronic lung disease (CLD) of the newborn is associated with pulmonary inflammation. However, the origin of this inflammation is not known. We evaluated the impact of airway infection on bronchoalveolar inflammation in mechanically ventilated preterm infant at risk for CLD (n = 68). Mean and maximum concentrations of the inflammatory mediators (IM) interleukin-1 and interleukin-8 were assayed in the tracheobronchial aspirate fluid (TAF) of neonates with perinatal airway infection (Ureaplasma urealyticum, or bacteria), postnatal nosocomial airway infection, or respiratory disease without airway infection from days 1-10 of postnatal age. Patients with CLD (n = 23;) exhibited increased levels of IM in TAF compared to neonates without CLD. Within the three subgroups, concentrations of IM were increased in CLD patients with perinatal infection and in CLD patients with respiratory disease without airway infection, but not in CLD patients with nosocomial airway infection. Although airway colonization with Gram-negative bacteria was more frequently found in CLD patients within the first month of life, there were no differences between levels of IM in patients colonized with Gram-negative bacteria or coagulase-negative staphyloccoci. We conclude that perinatal infections with Ureaplasma urealyticum or bacteria and respiratory disease without infection, but not nosocomial airway infection, contribute to the bronchopulmonary inflammatory response in neonates with CLD.


Subject(s)
Cross Infection/complications , Infant, Premature , Lung Diseases/complications , Pneumonia/complications , Respiratory Tract Infections/complications , Ureaplasma Infections/complications , Female , Humans , Immunoglobulin A, Secretory/analysis , Infant, Newborn , Infant, Very Low Birth Weight , Inflammation Mediators/analysis , Interleukin-1/analysis , Interleukin-8/analysis , Male , Perinatal Care , Prospective Studies , Respiration, Artificial , Trachea/metabolism
4.
Intensive Care Med ; 23(12): 1275-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9470085

ABSTRACT

OBJECTIVE: Case report on the effect of inhaled prostacyclin in a preterm infant (28 weeks gestational age) with respiratory distress syndrome complicated by marked hypoxemia due to persistent pulmonary hypertension of the newborn. Treatment with surfactant, hyperventilation, and elevation of systemic blood pressure had failed to improve oxygenation. MEASURES: A solution containing 10 micrograms PGI2/ml was aerosolized by the SPAG-2 aerosol-generator and then introduced into the afferent loop of the ventilatory circuit. RESULTS: Oxygenation improved dramatically and worsened when aerosolization was withdrawn. Intravenous prostacyclin had no additional effect on oxygenation. We observed no side effects on blood pressure and no bleeding complications. Inhalation was stopped after 40 hours and the baby was successfully weaned from the ventilator after 108 hours. CONCLUSION: Inhaled PGI2 had a beneficial effect on the oxygenation of a preterm neonate with persistent pulmonary hypertension of the newborn.


Subject(s)
Epoprostenol/therapeutic use , Infant, Premature , Persistent Fetal Circulation Syndrome/drug therapy , Respiratory Distress Syndrome, Newborn/complications , Vasodilator Agents/therapeutic use , Administration, Inhalation , Epoprostenol/administration & dosage , Humans , Hypoxia/etiology , Infant, Newborn , Treatment Outcome , Vasodilator Agents/administration & dosage , Ventilator Weaning
SELECTION OF CITATIONS
SEARCH DETAIL
...